Engineering an Innovative Chimeric Multi-Epitope RNA-Based Vaccine Against Neonatal Calf Diarrhea Pathogens (Bovine Coronavirus, Bovine Rotavirus, and Escherichia coli K99): An In Silico-Based Analysis

Immuno · Published 2026-07-29 · DOI 10.3390/immuno6030048

Free full text

Authors (4)

Mariam Hassan, Amjed Alsultan, Dhama Alsallami, Behrooz Sadeghi Kalani

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Hassan, M., Alsultan, A., Alsallami, D., et al. (2026). Engineering an Innovative Chimeric Multi-Epitope RNA-Based Vaccine Against Neonatal Calf Diarrhea Pathogens (Bovine Coronavirus, Bovine Rotavirus, and Escherichia coli K99): An In Silico-Based Analysis. Immuno. https://doi.org/10.3390/immuno6030048

Related articles

• Neurotoxic Effects of Metal and Metal Oxide Nanoparticles and the Protective Role of Natural Bioactive Compounds · Immuno · 2026 · Same journal
• Immune Evasion in Pancreatic Ductal Adenocarcinoma: Mechanistic Insights and Emerging Strategies to Reinvigorate Anti-Cancer Immunity · Immuno · 2026 · Same journal
• Nanobiotechnology-Based Strategies for Targeting Neuroinflammation and Neural Tissue Engineering · Immuno · 2026 · Same journal
• Identification and Prioritization of Neoantigens Derived from Non-Synonymous Mutations in Melanoma Through HLA Class I Binding Prediction · Immuno · 2026 · Same journal
• Immune Responses to Filarial Nematodes: A Mechanistic Evaluation of Evasion and Modulation Strategies · Immuno · 2025 · Same journal
• Harnessing Living Therapies: The Role of CAR-T Cells, Oncolytic Viruses, and Bacteria in Cancer Treatment · Immuno · 2026 · Same journal
• Cytokine Release Syndrome-like Reactions Following Exposure to Iodinated Contrast Media: A Case Series · Immuno · 2026 · Same journal
• Complement at the Nano–Neuroimmune Interface: A Hypothesis-Driven Perspective on Opioid Use Disorder · Immuno · 2026 · Same journal
• Development of a Multiplexed Fluorescent Pseudovirus Neutralization Test for Simultaneous Assessment of Immunity to Three SARS-CoV-2 Variants · Immuno · 2026 · Same journal
• Potential Target Line, FGFR3, EGFR and Immune Checkpoint Axis for Bladder Cancer Therapy · Immuno · 2026 · Same journal